Our markets are lower on a lack of catalysts and concerns about the upcoming earnings season. Edwards Lifesciences (EW) is the latest stock to take it on the chin after lowering Q3 guidance. The stock is down nearly 20% on the news and weighing on medical device stocks. [More...]